4.8 Article

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2

Journal

NATURE
Volume 463, Issue 7281, Pages 671-U104

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature08727

Keywords

-

Funding

  1. Wellcome Trust
  2. Medical Research Council (MRC) [G0500539]
  3. Swiss National Foundation [310000-112552, 33CSCO-122661]
  4. RCUK
  5. Swiss National Fund [320030_122674]
  6. Synapsis Foundation
  7. University of Lausanne
  8. Ludwig Institute for Cancer Research
  9. Swiss Institute of Bioinformatics
  10. le Conseil Regional Nord Pas de Calais/FEDER
  11. GlaxoSmithKline
  12. Faculty of Biology and Medicine of Lausanne
  13. Estonian Government [SF0180142s08]
  14. EU
  15. FP7 [201413 ENGAGE, 212111 BBMRI]
  16. ECOGENE [205419]
  17. Genome Canada
  18. Genome Quebec
  19. Swedish Research Council [K2008-65X-20753-01-4, K2007-55X-11285-13, 529-2002-6671]
  20. Swedish Foundation for Strategic Research
  21. Swedish Diabetes Foundation
  22. Ake Wiberg Foundation
  23. Foundations of the National Board of Health and Welfare
  24. Jeansson Foundations
  25. Magn Bergvall Foundation
  26. Tore Nilson Foundation
  27. Royal Physiographic Society
  28. INNOVA-VINNMER
  29. Swedish federal government
  30. INSERM
  31. CNAMTS
  32. Lilly
  33. Novartis Pharma
  34. Sanofi-Aventis
  35. Association Diabete Risque Vasculaire
  36. Federation Francaise de Cardiologie
  37. La Fondation de France
  38. ALFEDIAM
  39. ONIVINS
  40. Ardix Medical, Bayer Diagnostics
  41. Becton Dickinson
  42. Cardionics
  43. Merck Sante
  44. Novo Nordisk
  45. Pierre Fabre
  46. Roche and Topcon
  47. Academy of Finland [104781, 120315]
  48. University Hospital Oulu
  49. Biocenter, University of Oulu, Finland
  50. European Commission [QLG1-CT-2000-01643]
  51. NHLBI [5R01HL087679-02, 1RL1MH083268-01]
  52. NIH/NIMH [5R01MH63706: 02]
  53. ENGAGE [HEALTH-F4-2007-201413]
  54. [SF0180026s09]
  55. Medical Research Council [G0600331, G0900554] Funding Source: researchfish
  56. Swiss National Science Foundation (SNF) [320030_122674] Funding Source: Swiss National Science Foundation (SNF)
  57. MRC [G0600331, G0900554] Funding Source: UKRI

Ask authors/readers for more resources

Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western 'obesogenic' environment and a strong genetic contribution(1). Recent extensive genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms associated with obesity, but these loci together account for only a small fraction of the known heritable component(1). Thus, the 'common disease, common variant' hypothesis is increasingly coming under challenge(2). Here we report a highly penetrant form of obesity, initially observed in 31 subjects who were heterozygous for deletions of at least 593 kilobases at 16p11.2 and whose ascertainment included cognitive deficits. Nineteen similar deletions were identified from GWAS data in 16,053 individuals from eight European cohorts. These deletions were absent from healthy non-obese controls and accounted for 0.7% of our morbid obesity cases (body mass index (BMI) >= 40 kg m(-2) or BMI standard deviation score >= 4; P = 6.43 x 10(-8), odds ratio 43.0), demonstrating the potential importance in common disease of rare variants with strong effects. This highlights a promising strategy for identifying missing heritability in obesity and other complex traits: cohorts with extreme phenotypes are likely to be enriched for rare variants, thereby improving power for their discovery. Subsequent analysis of the loci so identified may well reveal additional rare variants that further contribute to the missing heritability, as recently reported for SIM1 (ref. 3). The most productive approach may therefore be to combine the 'power of the extreme'(4) in small, well-phenotyped cohorts, with targeted follow-up in case-control and population cohorts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available